GlobeNewswire Inc.··NaDianthus to Unveil Phase 3 CIDP Trial Data as Claseprubart Nears Potential Breakthrough
Dianthus Therapeutics will present interim responder analysis from Phase 3 CAPTIVATE trial of claseprubart for CIDP treatment on March 9, 2026.
DNTHclinical-stage biotechPhase 3 trial